Literature DB >> 19474516

Grade I lymphomatoid granulomatosis with increased uptake of [18F] fluorodeoxyglucose in positron emission tomography: a case report.

Hiromasa Arai1, Hisashi Oshiro, Sumitaka Yamanaka, Norio Yukawa, Nobuyuki Wada, Yasushi Rino, Yuji Watanuki, Shoji Yamanaka, Yoshiaki Inayama, Jin Lee, Haruhiko Nakayama, Munetaka Masuda.   

Abstract

There are several reports describing [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) findings in patients with lymphomatoid granulomatosis (LYG). We report a case of grade I LYG that showed increased uptake of FDG. The patient was a 63-year-old Japanese male who underwent an FDG-PET/computed tomography (CT) scan in screening for a malignant lesion. Increased uptake of FDG [maximum standard uptake value (SUV(max)), 3.7] was observed in the right hilar region in FDG-PET and enhanced CT revealed a round, abnormal mass that also showed increased FDG uptake. The patient had no previous symptoms. A tumor biopsy was performed and the histological diagnosis was grade I LYG. Therefore, increased SUV(max) in FDG-PET might be useful for diagnosing of LYG.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474516     DOI: 10.3960/jslrt.49.39

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  3 in total

1.  A surgical case of methotrexate-associated lymphomatoid granuloma.

Authors:  Hajime Watanabe; Ryota Masuda; Tomohiko Matsuzaki; Rurika Hamanaka; Yoichiro Ikoma; Takayuki Nakano; Kana Oiwa; Mitsutomo Kohno; Masayuki Iwazaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-12-19

2.  Lymphomatoid granulomatosis: CT and FDG-PET findings.

Authors:  Jonathan H Chung; Carol C Wu; Matthew D Gilman; Edwin L Palmer; Robert P Hasserjian; Jo-Anne O Shepard
Journal:  Korean J Radiol       Date:  2011-09-27       Impact factor: 3.500

3.  Cerebral and pulmonary lymphomatoid granulomatosis and EBV positive oesophageal ulcer in an immunosuppressed renal transplant patient staged and followed with serial MRI and 18F-FDG PET/CT after rituximab therapy.

Authors:  William Makis; Jean Deschenes
Journal:  BJR Case Rep       Date:  2016-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.